These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34803574)

  • 1. Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn.
    Dziegiel MH; Krog GR; Hansen AT; Olsen M; Lausen B; Nørgaard LN; Bergholt T; Rieneck K; Clausen FB
    Transfus Med Hemother; 2021 Oct; 48(5):306-315. PubMed ID: 34803574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
    Kent J; Farrell AM; Soothill P
    BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan.
    Moinuddin I; Fletcher C; Millward P
    J Blood Med; 2019; 10():283-289. PubMed ID: 31692490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report.
    Yousuf R; Abdul Aziz S; Yusof N; Leong CF
    J Med Case Rep; 2012 Feb; 6():71. PubMed ID: 22348809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
    Hyland CA; O'Brien H; Flower RL; Gardener GJ
    Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of RHD fetal genotype in RhD negative women.
    Kratochvílová T; Böhmová J; Durdová V; Vodička R; Holusková I; Langová K; Lubušký M
    Ceska Gynekol; 2020; 85(3):156-163. PubMed ID: 33562966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
    Quantock KM; Lopez GH; Hyland CA; Liew YW; Flower RL; Niemann FJ; Joyce A
    Transfusion; 2017 Aug; 57(8):1938-1943. PubMed ID: 28639307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal
    Schimanski B; Kräuchi R; Stettler J; Lejon Crottet S; Niederhauser C; Clausen FB; Fontana S; Hodel M; Amylidi-Mohr S; Raio L; Abbal C; Henny C
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report on non-D HDFN: Highlighting the role of antibody screening in RhD positive antenatal women.
    Singh B; Chaudhary R; Elhence P; Bharati JK; Srivastava A
    Asian J Transfus Sci; 2022; 16(1):121-123. PubMed ID: 36199394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North India.
    Sidhu M; Bala R; Akhtar N; Sawhney V
    Indian J Hematol Blood Transfus; 2016 Sep; 32(3):307-11. PubMed ID: 27429523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
    Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive fetal RhD genotyping.
    Clausen FB; Damkjær MB; Dziegiel MH
    Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.